Howard Kaplan, MD
Ophthalmology · Poughkeepsie, NYNPI 1134224702
Payments from drug & device makers
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
How this compares
$0 in reported general payments places this provider in the 0th percentile of 1,587 ophthalmology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Loteprednol Etabonate | 47 | $6,186 |
| Prednisolone Acetate | 53 | $2,510 |
| Atropine Sulfate | 17 | $736 |
| Ofloxacin | 41 | $704 |
| Latanoprost | 29 | $263 |
| Cyclopentolate Hcl | 12 | $131 |
| Tramadol Hcl | 25 | $46 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Poughkeepsie
- Satish ModiPoughkeepsie$765K
- Douglas JabsNew York$24.3M
- David RubaltelliBrooklyn$8.9M
- Philip FerroneGreat Neck$5.8M
- Eric DonnenfeldGarden City$2.6M
- Nathan RadcliffeNew York$2.4M
- Glenn StollerRockville Centre$2.1M
- Richard SpaideNew York$1.7M
- Paul HartmanRochester$1.6M
- Jason SlakterNew York$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.